TheStreet upgraded shares of Neptune Technologies & Bioresources Inc. (NASDAQ:NEPT) (TSE:NTB) from a d rating to a c- rating in a research report sent to investors on Friday morning.
Shares of Neptune Technologies & Bioresources (NASDAQ:NEPT) traded down 3.57% during midday trading on Friday, hitting $1.08. 119,085 shares of the stock traded hands. The stock has a market cap of $84.18 million, a price-to-earnings ratio of 14.03 and a beta of 0.67. The firm has a 50-day moving average price of $1.01 and a 200 day moving average price of $1.05. Neptune Technologies & Bioresources has a one year low of $0.86 and a one year high of $1.53.
About Neptune Technologies & Bioresources
Neptune Technologies & Bioressources Inc is a solution provider of omega-3’s and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids.